Navigation Links
Treatment for Syndrome X

Syndrome X is a disorder that many people are at risk for developing by the time they reach middle age. Syndrome X is why many people feel lousy and tired all the time, and it can put them at risk// for health problems such as heart disease, diabetes, Alzheimer's, cancer and other age-related diseases.

Syndrome X refers specifically to the health problems that include insulin resistance, abnormal blood fats, overweight and high blood pressure. New research shows an effective solution for syndrome X is the combination of exercise and weight loss.

Researchers conducted a study to determine if a six-month intervention could have an effect on coronary heart disease risk factors associated with syndrome X.

The study included 53 men and women who were part of a larger clinical trial. The participants suffered from insulin resistance, abnormal blood fats and high blood pressure. They were randomly assigned to the exercise only group, exercise and structured weight-loss program group, or the group that was on the waiting list for treatment. Before and after treatment, the participants underwent a variety of tests including glucose tolerance, lipid levels and blood pressure measurements.

Researchers found the response to glucose in the body was significantly reduced in both the exercise only and exercise/weight-loss groups. They say participants who lost the most amount of weight showed the most improvements in abnormal insulin responses. Researchers also report the diastolic blood pressure level was significantly reduced in the exercise/weight-loss group, but not in the exercise only group. The lipid or fat profile was not significantly improved in either intervention group.

Researchers thus conclude, the combination of exercise and weight loss is an effective treatment for hyperinsulinemia (failure of blood sugar control system) and lowering diastolic blood pressure in patients with syndrome X.


'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Treatment for Syndrome

(Date:12/4/2008)... The January issue of European Urology , the off...gy published by Elsevier, will feature new recomme...y formulated by major scientific organizations. LO...d with advancing age and characterized by typical ...vels. , Late-onset hypogonadism (LOH) is caused...
(Date:12/4/2008)... 4, 2008 In a decision to focus full attention an...es, USP will transfer its reporting programs, MEDM...ram, to Quantros and the Institute for Safe Medica... in no way signals a shift by USP away from its im...se data from these and other programs to enhance i...
(Date:12/4/2008)...region achieves measles goal three years early , ...GTON, Dec. 4 Measles de...from an estimated 750,000 to 197,000. In addition,... countries such as Afghanistan, Pakistan, Somalia,...ble 90% -- from an estimated 96,000 to 10,000 -- d...
(Date:12/4/2008)...c. 4 AARP CEO Bill Nove...tion to the latest Congressional efforts to help f...ewscom.com/cgi-bin/prnh/20070209/NYF043LOGO ) , ...nly get worse if we allow America,s biggest automa...ting these corporations go under -- taking with th...
Breaking Medicine News(10 mins):Health News:New recommendations by scientific societies about late-onset hypogonadism 2Health News:USP transitions medication error reporting programs 2Health News:USP transitions medication error reporting programs 3Health News:Global Measles Deaths Drop By 74% 2Health News:Global Measles Deaths Drop By 74% 3Health News:Global Measles Deaths Drop By 74% 4Health News:Global Measles Deaths Drop By 74% 5Health News:AARP: Health Care and Pension Reform Critical to Economic Recovery 2Health News:AARP: Health Care and Pension Reform Critical to Economic Recovery 3
...pating in the 'Pongala Mahotsavam,' festival at th...usively for the women folk. //The festival began o...March 14. 'Pongala Mahotsavam' is considered a ve...f this temple, which is perhaps one of the oldest ...
...tment had been in the forefront, monitoring the He... now initiated checks on the documentation of the ...o bird brought from Navpur in Maharashtra is still...s and animal disease experts will be overseeing th...
...ve identified the deadly H5N1 virus in geese, duck...ern China, sparking fears of bird flu pandemic//. ...al hosts of the bird flu virus. This however is th...atic bird flu infection has been detected among se...
... report by the American Medical Association has le... and their wild (s) ways!// A survey of 644 femal...of control and going really berserk is their take ...ur women seem to get drunk and use this excuse for...
Other Medicine News:Health News:Healthy, Bird Flu Infected Chickens In Chinese Markets 2
(Date:12/2/2008)...e/ -- Researchers using functional,MRI (fMRI) hav... brain,responsible for suppressing memory is dysf...ed psychiatric disorders. Results of the study wil... Radiological Society of North America,(RSNA). ,...er stress-related disorders,traumatic memories a...
(Date:12/2/2008)...Horizon Therapeutics, Inc., a,privately held biop...votal,Phase 3 trials evaluating its lead investig...ry endpoints. HZT-501, a novel, proprietary fixed-... famotidine, demonstrated a,statistically signifi...anti-inflammatory drug (NSAID)-induced upper gastr...
(Date:12/1/2008)...geGen has announced that an oral,presentation of ... clinical,trial of TG101348 in myeloproliferative...American Society of Hematology (ASH) Meeting. , ..., Title: A Phase I Study of TG1... JAK2-Selective Inhibitor, in Patients with, ...
(Date:12/1/2008)...licy , , ROCHESTER, Minn., Dec. 1 /PRNewsw...nds the use of the drug therapy etanercept ineffec...lammation of the liver caused by excessive consump...ished in the December issue of Gastroenterology ...EO ALERT: Additional audio and video resources, in...
Breaking Medicine Technology:Stress-Related Disorders Affect Brain's Processing of Memory 2Stress-Related Disorders Affect Brain's Processing of Memory 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Avantis Medical Systems Inc Announces Key Leadership Appointments 7313 1Avantis Medical Systems Inc Announces Key Leadership Appointments 7313 23SBio Inc to Present at the Morgan Stanley Global Healthcare Unplugged Conference 7311 1One Third of Schools Built in Air Pollution Danger Zones 25755 1One Third of Schools Built in Air Pollution Danger Zones 25755 2 Integrated Project Management Named to 26quot 3BInc 5000 26quot 3B for Second Year 3A One of the Top 100 Fastest Growing Companies in Chicago Are 7309 1 Integrated Project Management Named to 26quot 3BInc 5000 26quot 3B for Second Year 3A One of the Top 100 Fastest Growing Companies in Chicago Are 7309 2
...ire-FirstCall/ --,NeurogesX, Inc. announced today ...Phase 3 trial in postherpetic neuralgia (PHN).,Mis... at University,of Wisconsin in Madison and lead ac...to present the results of the study in a,June 8 po...on,Neuropathic Pain in Berlin, Germany. Dr. Backon...
...Society,s 11th,International Congress in Istanbul,...re-FirstCall/ -- New,information on the use of AZI...Parkinson,s disease (PD) was reported this week at...bul, Turkey.,Once-daily AZILECT was approved by th... and symptoms of PD, both as initial,monotherapy a...
Other Medicine Technology:NeurogesX Announces Presentation of Positive Phase 3 Clinical Data,at the Second International Congress on Neuropathic Pain Meeting,(NeuPSIG) 2NeurogesX Announces Presentation of Positive Phase 3 Clinical Data,at the Second International Congress on Neuropathic Pain Meeting,(NeuPSIG) 3NeurogesX Announces Presentation of Positive Phase 3 Clinical Data,at the Second International Congress on Neuropathic Pain Meeting,(NeuPSIG) 4International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 2International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 3International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 4International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 5International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 6
1 mm wide by 28 mm long sterling silver blade. Flat serrated handle with polished finish.
Double ended lasik spatula with flattened tip for lifting and smoothing the corneal flap. The sharp tip is useful to outline a previous flap in preparation for retreatment.
Serrated rake tip spatula with 20 gauge shaft. Black finish for reduced glare. Can be used with 20 gauge MVR blades.
Rounded tip spatula with 20 gauge shaft. Black finish for reduced glare.
Medicine Products: